BeiGene | Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

⟵ Back to Search Results

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Beigene Study ID

BGB-A317-206

ClinicalTrials.gov ID

NCT03432598

China Drug Trials ID

CTR20170361

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Sex: All

Age: 18 Years / 75 Years

No Study Documents